Fonar MRI patent trial is postponed

Article

The judge hearing patent litigationbetween MRI manufacturer Fonar and competitors GE and Hitachihas postponed a trial date for the case. The litigation, in whichFonar is suing GE, Hitachi and two imaging centers for violatingits basic MRI patents, was

The judge hearing patent litigationbetween MRI manufacturer Fonar and competitors GE and Hitachihas postponed a trial date for the case. The litigation, in whichFonar is suing GE, Hitachi and two imaging centers for violatingits basic MRI patents, was scheduled to go to trial Dec. 5 inU.S. District Court for Eastern New York in Hauppauge, NY. Fonaris claiming damages of $362 million from the defendants (SCAN11/23/94).

The judge delayed the start of the trial because the litigantshave not yet agreed on the appointment of an independent expertwho will instruct the judge and jury in the basics of MRI technology,according to Fonar counsel Ronald Schutz of Robins, Kaplan, Millerand Ciresi in Minneapolis. A new date has not been set for thetrial, although Schutz believes it should begin in the next severalmonths.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.